OptimizeRx and Questex’s Fierce Life Sciences Tackle Industry’s Top Challenges in Design Thinking Event, Innovate4Outcome...
17 November 2020 - 4:30PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has partnered with information services provider, Fierce
Life Sciences, to develop a collaborative, design thinking event to
tackle some of the biggest challenges facing healthcare.
The event will bring together some of the industry’s most
prominent thought leaders to innovate solutions for new and
traditional healthcare challenges.
The onset of COVID-19 in the first quarter of 2020 forced
everyone to adapt to a rapid expansion of digital healthcare
options and the new widespread challenge of delayed treatments.
With this event, OptimizeRx, in partnership with Fierce Life
Sciences, offers a unique opportunity for participants to
collaborate with thought leaders and brainstorm solutions to the
following challenges:
- As face-to-face interactions remain
off the table until at least the middle of 2021, what more can be
done to virtually support providers in delivering appropriate
care?
- What role can clinicians play in
directing digital strategies that encourage patients to follow
recommended courses of treatment and achieve positive
outcomes?
- Patient support programs are largely
unadopted, but providers report that they can successfully promote
patient outcomes. What can be done to further empower patients to
utilize support programs?
- Social media can have a huge impact
on patients. How can social media and other channels be harnessed
to shape authentic engagement experiences for patients and improve
health outcomes?
“As we continue to navigate the lasting impact of COVID-19 on
our healthcare infrastructure, we believe it is essential that we
continually collaborate and partner with leading experts in life
sciences and care delivery,” commented Steve Silvestro, chief
commercial officer at OptimizeRx. “These partnerships and
collaborations help ensure that we are not only supporting but
cultivating innovation. We are thrilled to bring together these
excellent thought leaders for this event, where we can collaborate
on actionable solutions that address the real-world problems faced
today by providers and patients.”
Innovate4Outcomes team leads include:
Ray Gomez - Director of Worldwide Omni-Channel Content and
Channel Strategy, BD
Hiyam Nadel RN, MBA, CCG - Director of the Center for
Innovations in Care Delivery, Massachusetts General Hospital
Neal Wolff - Vice President, Marketing, Nevakar, Inc.
Ritesh Patel - Chief Digital Officer, Ogilvy Health
Angelo Campano - SVP, Principal, Agency Channels, OptimizeRx
Steve Silvestro - Chief Commercial Officer, OptimizeRx.
See full list of team leads here.
Innovate4Outcomes Virtual
Event Date: Thursday, December 3, 2020
Time: 2:00 pm - 4:00 p.m. EST.
Register at www.fiercelifesciences.com/Innovate4Outcomes
Attendance will be limited to
100 participants.
About QuestexQuestex helps
people live better and longer. Questex brings people together in
the markets that help people live better: travel, hospitality and
wellness; the industries that help people live longer: life science
and healthcare; and the technologies that enable and fuel these new
experiences. We live in the experience economy - connecting our
ecosystem through live events, surrounded by data insights and
digital communities. We deliver experience and real results. It
happens here. For more information, visit questex.com.
About OptimizeRxOptimizeRx is a digital health
company that provides communications solutions for life science
companies, physicians and patients. Connecting over half of
healthcare providers in the U.S. and millions of patients through a
proprietary network, the OptimizeRx digital health platform helps
patients afford and stay on medications. The platform unlocks new
patient and physician touchpoints for life science companies along
the patient journey, from point-of-care, to retail pharmacy,
through mobile patient engagement.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx Contact Doug Baker, CFOTel
(248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754)
245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024